Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS-mutated chronic myelomonocytic leukemia https://www.biorxiv.org/content/10.1101/2023.04.07.535928v1?med=mas
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS-mutated chronic myelomonocytic leukemia https://www.biorxiv.org/content/10.1101/2023.04.07.535928v1?med=mas